Sinus Balloon Dilation in Pediatric Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02278484
Recruitment Status : Completed
First Posted : October 30, 2014
Results First Posted : December 7, 2016
Last Update Posted : April 11, 2017
Information provided by (Responsible Party):
Entellus Medical, Inc.

Brief Summary:
Safety and effectiveness of sinus balloon dilation in patients 2-21 years old.

Condition or disease Intervention/treatment
Sinusitis Device: XprESS device and PathAssist confirmation tools

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 50 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: XprESS Device and PathAssist Confirmation Tools in Pediatric Patients-Expanded Indication Study
Study Start Date : September 2014
Primary Completion Date : September 2015
Study Completion Date : January 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sinusitis
U.S. FDA Resources

Arm Intervention/treatment
Balloon Sinus Dilation Device: XprESS device and PathAssist confirmation tools

Primary Outcome Measures :
  1. Technical Success: Sinuses Successfully Treated With Balloon Dilation [ Time Frame: Index procedure ]
    Number of successful dilations out of all attempted dilations. Success is defined as the device successfully delivered to the target sinus, inflated, deflated, and withdrawn from the treated sinus.

  2. Complications [ Time Frame: Index procedure through 3-month follow-up ]
    Number of subjects who experience complications. Complications are defined as serious device or procedure related adverse events.

Secondary Outcome Measures :
  1. Change in Quality of Life From Baseline Through Completion [ Time Frame: Baseline to 6-month follow-up ]
    Change in sinonasal symptom severity between the baseline preprocedure assessment and follow-up assessment. Sinus symptom severity is measured using the Sinus and Nasal Quality of Life Survey (SN-5) that is a validated tool for use in pediatric patients (completed by caregivers). The 5 survey items are scored from 1 (best) to 7 (worst) and averaged to provide an overall score.

  2. Number of Subjects Who Undergo a Revision or Additional Surgery During the Study [ Time Frame: Procedure-6 month follow up ]
    Any surgical intervention that is performed in the sinus(es) following the index procedure will be reported

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   2 Years to 21 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

Patients age ≥ 2 to ≤ 21 years old. Diagnosed with Chronic Rhinosinusitis (CRS). Candidate for trans-nasal balloon sinus dilation.

Exclusion Criteria:

History of sinus surgery. Recent nasal or head and neck surgery. Fungal sinus disease. Severe asthma. Cystic fibrosis. Immunodeficiency. Craniofacial abnormalities. Pregnancy (current)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02278484

United States, Arizona
North Valley ENT
Phoenix, Arizona, United States, 85032
United States, Oregon
Willamette ENT and Facial Plastic Surgery
Salem, Oregon, United States, 97302
United States, South Carolina
Medical University of South Carolina
Charleston, South Carolina, United States, 29425
United States, Texas
Alamo ENT and Associates
San Antonio, Texas, United States, 78258
Sponsors and Collaborators
Entellus Medical, Inc.

Publications of Results:
Responsible Party: Entellus Medical, Inc. Identifier: NCT02278484     History of Changes
Other Study ID Numbers: 2827-001
First Posted: October 30, 2014    Key Record Dates
Results First Posted: December 7, 2016
Last Update Posted: April 11, 2017
Last Verified: February 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Entellus Medical, Inc.:
sinus infections
chronic sinusitis
allergic sinusitis
allergic rhinitis
chronic rhinosinusitis
sinus disease in children
sinus balloon dilation
balloon dilatation
sinus disease

Additional relevant MeSH terms:
Paranasal Sinus Diseases
Nose Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Otorhinolaryngologic Diseases